Sanitas AB received the information from its shareholder Invalda AB that it has executed definitive documentation to transfer a 20.3 % interest in Sanitas AB to Baltic Pharma Limited, an investment vehicle for funds managed by Citi Venture Capital International (CVCI). The closing of the sale is subject to certain conditions precedent including obtaining required regulatory approvals. The transaction is expected to close in Q1 2009. The transaction results in no change to the total ownership held by the group of controlling shareholders of Sanitas (i.e. Invalda, CVCI-advised entities and funds managed by Danske Capital and Firebird Management LLC), which jointly continue to hold more than 80 % of the Company. Jurist Alina Nausedaite + 370 37 20 06 62